Yes, I would be happy to respond to that statement.
The last time I was here, we were talking about federally funded health research. Some of you may remember that we talked about different models of incentivizing research and making sure that the products of research are available to all who need them at the end of the day.
Part of the rhetoric you talked about is that it costs so much to bring a new drug to the market that we have to recoup those costs, and if we don't invest and we don't sell these drugs for an arm and a leg, innovation is going to die. We know that's not true. We know there are models that are working and producing drugs on a different model from the one we're looking at right now. We know a lot of drugs are publicly funded, so that rhetoric is inaccurate and false.
It's not surprising to me that you're getting that organized push-back.